We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DG:EURONEXT PARISVINCI SA Analysis

Data as of 2026-05-21 - not real-time

$104.61

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Dollar General (DG) trades at $104.61, well below its 20‑day, 50‑day and 200‑day moving averages, signaling a bearish technical backdrop, while the RSI of 36 hints at near‑oversold conditions and a modest bounce potential. Fundamentally, the company delivers solid revenue growth of ~6% YoY, a respectable ROE of almost 19%, and a dividend yield of 2.26% backed by a payout ratio under 35%, suggesting dividend sustainability despite a high debt‑to‑equity ratio of ~185%.
Valuation metrics are mixed: the DCF‑derived fair value of roughly $96 places the stock modestly above intrinsic estimates, yet a low price‑to‑sales multiple of 0.54 and analyst consensus calling the stock a “buy” with median target near $143 imply upside potential. The blend of defensive sector positioning, increasing volume, and strong cash flow supports a cautiously optimistic outlook, tempered by elevated volatility (≈38% 30‑day) and leverage concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near the identified support level of $100.21
  • Bearish SMA alignment but RSI approaching oversold territory
  • Rising volume suggests potential short‑term buying interest

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus target median around $143 indicating upside
  • Strong cash generation and dividend yield of 2.26% with low payout ratio
  • Revenue growth and defensive consumer‑discretionary positioning

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High debt‑to‑equity ratio may constrain future flexibility
  • Sustained dividend and solid ROE support shareholder value
  • Discount‑store sector offers defensive resilience over economic cycles

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin3.54%
P/E Ratio15.3
ROE18.99%
ROA4.55%
Debt/Equity184.66
P/B Ratio2.7
Op. Cash Flow$3.6B
Free Cash Flow$2.2B

Technical Analysis

TrendBearish
RSI36.6
Support$100.21
Resistance$123.67
MA 20$111.46
MA 50$118.87
MA 200$121.26
MACDBearish
VolumeIncreasing
Fear & Greed Index90.29

Valuation

Fair Value$95.92
Target Price$144.18
Upside/Downside37.82%
GradeFair
TypeValue
Dividend Yield2.26%

Risk Assessment

Beta0.55
Volatility38.60%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.